Decoding (patho-) physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies

CV Montefusco-Pereira… - Drug Discovery …, 2021 - Elsevier
In 2017, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) identified
lower respiratory tract infections as the 4 th leading causes for early death worldwide …
被引用次数：7 相关文章

Decoding (patho-) physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies.

CV Montefusco-Pereira, CS Carvalho-Wodarz… - 2020 - repository.helmholtz-hzi.de
Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel
anti-infectives therapies Carlos Victor Page 1 1 Decoding (patho-)physiology of the lung by …

[引用][C] Decoding (patho-) physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies

CV Montefusco-Pereira… - Drug discovery …, 2021 - pubmed.ncbi.nlm.nih.gov
Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel
anti-infectives therapies Decoding (patho-)physiology of the lung by advanced in vitro models …

[引用][C] Decoding (patho-) physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies.

CV Montefusco-Pereira, CS Carvalho-Wodarz… - Drug Discovery …, 2020 - europepmc.org
Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel
anti-infectives therapies. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …